+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AB Science - logo

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

From
cFMS Kinase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

cFMS Kinase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Alzheimer's Disease: Competitive Landscape to 2026 - Product Thumbnail Image

Alzheimer's Disease: Competitive Landscape to 2026

  • Report
  • June 2018
  • 49 Pages
  • Global
From
From
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 576 Pages
  • Global
From
From
Metastatic Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Systemic Mastocytosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Mastocytosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 203 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 868 Pages
  • Global
From
Multiple Sclerosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1114 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • May 2024
  • 183 Pages
  • Global
From
Loading Indicator